Medical Plastics Market To Rise At Modest Growth With CAGR And Revenue Till 2030|Grand View Research, Inc.Posted by Mrudula Karmarkar on October 3rd, 2022 The global medical plastics market is anticipated to reach USD 88.40 billion by 2030, registering a CAGR of 7.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing demand for existing and new medical technologies, the aging population, and the growth in medical device applications. Plastics are increasingly becoming a vital part of medical devices as they offer better biocompatibility and optical clarity, and are economical to use. Plastics exhibit good chemical resistance, have good sterilization capability and are biocompatible. Although, on the contrary, a very selective number of polymers qualify for application in this segment as a medical-grade plastic. Multiple regulatory frameworks are now in place globally that decide which grades of plastics qualify for medical applications following research on the effect of such plastics after they come in contact with body fluids, internal and external tissue, etc. New product development, capacity development, and acquisitions are the three major strategies adopted by the companies to capture the market share. From 2022 to 2022, new product development was observed as the prime growth strategy adopted by the major medical plastic manufacturers such as SABIC, Solvay S.A., Celanese Corporation, Eastman Chemical Company, and Dow Inc. In addition, companies such as Solvay S.A., Rochling Group, Dow Inc, HMC Polymers, and Trelleborg also resorted to capacity expansion in order to increase their market share and revenue. In November 2020, SABIC introduced new polycarbonate-based CRX copolymer resins at BIOMEDigital 2020. This new product innovation is intended to reduce the premature failure from environmental stress cracking (ESC) in medical equipment housings and devices. The market also saw numerous acquisitions by major players. For example, Nolato AB acquired GW Plastics Inc in September 2020, Saint-Gobain Life Sciences acquired MS Techniques and Transluminal in September 2020, Tekni-Plex Healthcare acquired precision extrusion manufacturer Johnson Plastic Group in October 2021, Proxy Biomedical Ltd and Aran Biomedical were acquired by Integer holdings in April 2022. To Request Sample Copy of this report, click the link: https://www.grandviewresearch.com/industry-analysis/medical-plastics-market/request/rs1 The growing geriatric population in North America, Europe, and Asian countries like Japan and the increasing demand for home healthcare are the major factors driving the growth of medical plastics. Enforcement & upgrading of various infection prevention standards coupled with a growing volume of surgical, hospital, and outpatient procedures are anticipated to drive the market growth over the forecast period. Fluctuation in oil prices has been a major factor responsible for volatility in the prices of polyethylene (PE), polypropylene (PP), and polycarbonate (PC). Capacity expansion and contraction have also contributed to price volatility in the market. Medical Plastics Market Report Highlights
The medical plastics market in the U.S. was valued at USD 13.17 billion in 2021. The growing elderly population and growing demand for at-home healthcare are expected to drive the market over the forecast period. According to the latest U.S. census, 16.5% of the U.S. population, i.e., 54 million, is over the age of 65. By 2030, this number is expected to rise to 74 million. The number of people over the age of 85, who need the most care, is growing even faster. The global market key players operating in the market are Solvay S.A. Celanese Corporation, Eastman Chemical Company, Dow, SABIC, and Evonik Industries AG, along with a few medium and small regional players. Established players are developing new products through R&D suitable for medical applications. For instance, in March 2022, Evonik Industries AG announced VESTAKEEP iC4800 3DF, a new osteoconductive PEEK (polyether ether ketone) filament that improves fusion between bones and implants. Some of the prominent players operating in the global medical plastics market include
Like it? Share it! More by this author |